Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: July 4, 2024
T
lymphocytes
play
a
primary
role
in
the
adaptive
antiviral
immunity.
Both
lymphocytosis
and
lymphopenia
were
found
to
be
associated
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
While
indicates
an
active
anti-viral
response,
is
sign
of
poor
prognosis.
T-cells,
essence,
rarely
express
ACE2
receptors,
making
cause
cell
depletion
enigmatic.
Moreover,
emerging
strains
posed
immunological
challenge,
potentially
alarming
for
next
pandemic.
Herein,
we
review
how
possible
indirect
direct
key
mechanisms
could
contribute
SARS-CoV-2-associated-lymphopenia.
The
fundamental
mechanism
inflammatory
cytokine
storm
elicited
by
viral
infection,
which
alters
host
metabolism
into
more
acidic
state.
This
"hyperlactic
acidemia"
together
suppresses
T-cell
proliferation
triggers
intrinsic/extrinsic
apoptosis.
SARS-CoV-2
infection
also
results
shift
from
steady-state
hematopoiesis
stress
hematopoiesis.
Even
low
expression,
presence
cholesterol-rich
lipid
rafts
on
activated
T-cells
may
enhance
entry
syncytia
formation.
Finally,
indicate
participation
other
receptors
or
auxiliary
proteins
that
can
work
alone
concert
mechanisms.
Therefore,
address
CD147-a
novel
route-for
its
new
variants.
CD147
not
only
expressed
but
it
interacts
co-partners
orchestrate
various
biological
processes.
Given
these
features,
appealing
candidate
pathogenicity.
Understanding
molecular
cellular
behind
SARS-CoV-2-associated-lymphopenia
will
aid
discovery
potential
therapeutic
targets
improve
resilience
our
immune
system
against
this
rapidly
evolving
virus.
Cell Death and Differentiation,
Journal Year:
2022,
Volume and Issue:
29(6), P. 1107 - 1122
Published: May 17, 2022
Abstract
The
coronavirus
disease
2019
(COVID-19)
has
been
a
global
pandemic
for
more
than
2
years
and
it
still
impacts
our
daily
lifestyle
quality
in
unprecedented
ways.
A
better
understanding
of
immunity
its
regulation
response
to
SARS-CoV-2
infection
is
urgently
needed.
Based
on
the
current
literature,
we
review
here
various
virus
mutations
evolving
manifestations
along
with
alterations
immune
responses
specific
focuses
innate
response,
neutrophil
extracellular
traps,
humoral
immunity,
cellular
immunity.
Different
types
vaccines
were
compared
analyzed
based
their
unique
properties
elicit
Various
therapeutic
strategies
such
as
antibody,
anti-viral
medications
inflammation
control
discussed.
We
predict
that
available
continuously
emerging
new
technologies,
powerful
administration
schedules,
effective
public
health
measures,
COVID-19
will
be
under
near
future.
Current Opinion in Immunology,
Journal Year:
2022,
Volume and Issue:
74, P. 172 - 182
Published: Jan. 25, 2022
Type
I
interferons
(IFNs)
have
broad
and
potent
antiviral
activity.
We
review
the
interplay
between
type
IFNs
SARS-CoV-2.
Human
cells
infected
with
SARS-CoV-2
in
vitro
produce
low
levels
of
IFNs,
proteins
can
inhibit
various
steps
IFN
production
response.
Exogenous
viral
growth
vitro.
In
animal
species
vivo,
deficiencies
underlie
higher
loads
more
severe
disease
than
control
animals.
The
early
administration
exogenous
improves
infection
control.
humans,
inborn
errors
of,
auto-antibodies
against
life-threatening
COVID-19
pneumonia.
Overall,
are
essential
for
host
defense
individual
whole
organisms.
Cell Communication and Signaling,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: May 15, 2023
Coronavirus
disease
2019
(COVID-19)
is
caused
by
a
new
member
of
the
Coronaviridae
family
known
as
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
There
are
structural
and
non-structural
proteins
(NSPs)
in
genome
this
virus.
S,
M,
H,
E
proteins,
NSPs
include
accessory
replicase
proteins.
The
NSP
components
SARS-CoV-2
play
an
important
role
its
infectivity,
some
them
may
be
pathogenesis
chronic
diseases,
including
cancer,
coagulation
disorders,
neurodegenerative
cardiovascular
diseases.
interact
with
targets
such
angiotensin-converting
enzyme
(ACE2)
receptor.
In
addition,
can
stimulate
pathological
intracellular
signaling
pathways
triggering
transcription
factor
hypoxia-inducible
factor-1
(HIF-1),
neuropilin-1
(NRP-1),
CD147,
Eph
receptors,
which
roles
progression
diseases
like
Alzheimer's
disease,
epilepsy,
multiple
sclerosis,
cancers
glioblastoma,
lung
malignancies,
leukemias.
Several
compounds
polyphenols,
doxazosin,
baricitinib,
ruxolitinib
could
inhibit
these
interactions.
It
has
been
demonstrated
that
spike
protein
stronger
affinity
for
human
ACE2
than
SARS-CoV,
leading
current
study
to
hypothesize
newly
produced
variant
Omicron
receptor-binding
domain
(RBD)
binds
more
strongly
primary
strain.
SARS
Middle
East
(MERS)
viruses
against
have
become
resistant
previous
vaccines.
Therefore,
review
recent
studies
performance
vaccines
their
effects
on
COVID-19
related
vital
need
deal
conditions.
This
examines
potential
initiation
it
anticipated
serve
effective
vaccine
or
treatment
Video
Abstract.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 8034 - 8034
Published: April 28, 2023
Patients
who
have
recovered
from
coronavirus
disease
2019
(COVID-19)
infection
may
experience
chronic
fatigue
when
exercising,
despite
no
obvious
heart
or
lung
abnormalities.
The
present
lack
of
effective
treatments
makes
managing
long
COVID
a
major
challenge.
One
the
underlying
mechanisms
be
mitochondrial
dysfunction.
Severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infections
can
alter
mitochondria
responsible
for
energy
production
in
cells.
This
alteration
leads
to
dysfunction
which,
turn,
increases
oxidative
stress.
Ultimately,
this
results
loss
integrity
and
cell
death.
Moreover,
viral
proteins
bind
complexes,
disrupting
function
causing
immune
cells
over-react.
over-reaction
inflammation
potentially
symptoms.
It
is
important
note
that
roles
damage
inflammatory
responses
caused
by
SARS-CoV-2
development
are
still
being
elucidated.
Targeting
provide
promising
new
clinical
approaches
long-COVID
patients;
however,
further
studies
needed
evaluate
safety
efficacy
such
approaches.
Nature,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 29, 2025
Zoonoses
are
infectious
diseases
transmitted
from
animals
to
humans.
Bats
have
been
suggested
harbour
more
zoonotic
viruses
than
any
other
mammalian
order1.
Infections
in
bats
largely
asymptomatic2,3,
indicating
limited
tissue-damaging
inflammation
and
immunopathology.
To
investigate
the
genomic
basis
of
disease
resistance,
Bat1K
project
generated
reference-quality
genomes
ten
bat
species,
including
potential
viral
reservoirs.
Here
we
describe
a
systematic
analysis
covering
115
that
revealed
signatures
selection
immune
genes
prevalent
orders.
We
found
an
excess
gene
adaptations
ancestral
chiropteran
branch
many
descending
lineages,
highlighting
entry
detection
factors,
regulators
antiviral
inflammatory
responses.
ISG15,
which
is
contributing
hyperinflammation
during
COVID-19
(refs.
4,5),
exhibits
key
residue
changes
rhinolophid
hipposiderid
bats.
Cellular
infection
experiments
show
species-specific
differences
essential
role
protein
conjugation
function
separate
its
secretion
Furthermore,
contrast
humans,
ISG15
most
has
strong
anti-SARS-CoV-2
activity.
Our
work
reveals
molecular
mechanisms
contribute
tolerance
resistance
A
genomes,
10
new
positive
shows
aid
bats,
coronaviruses.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: Jan. 7, 2025
Abstract
The
mucosal
immune
system,
as
the
most
extensive
peripheral
network,
serves
frontline
defense
against
a
myriad
of
microbial
and
dietary
antigens.
It
is
crucial
in
preventing
pathogen
invasion
establishing
tolerance.
A
comprehensive
understanding
immunity
essential
for
developing
treatments
that
can
effectively
target
diseases
at
their
entry
points,
thereby
minimizing
overall
impact
on
body.
Despite
its
importance,
our
knowledge
remains
incomplete,
necessitating
further
research.
outbreak
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
underscored
critical
role
disease
prevention
treatment.
This
systematic
review
focuses
dynamic
interactions
between
mucosa-associated
lymphoid
structures
related
diseases.
We
delve
into
basic
functions
these
tissues
during
processes
explore
intricate
regulatory
networks
mechanisms
involved.
Additionally,
we
summarize
novel
therapies
clinical
research
advances
immunity-related
also
addresses
challenges
vaccines,
which
aim
to
induce
specific
responses
while
maintaining
tolerance
non-pathogenic
microbes.
Innovative
therapies,
such
nanoparticle
vaccines
inhalable
antibodies,
show
promise
enhancing
offer
potential
improved
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: Feb. 15, 2025
Cerebral
endothelial
cells
(CEC)
that
form
the
brain
capillaries
are
principal
constituents
of
blood
barrier
(BBB),
main
active
interface
between
and
which
plays
a
protective
role
by
restricting
infiltration
pathogens,
harmful
substances
immune
into
while
allowing
entry
essential
nutrients.
Aberrant
CEC
function
often
leads
to
increased
permeability
BBB
altering
bidirectional
communication
bloodstream
facilitating
extravasation
brain.
In
addition
their
as
gatekeepers
BBB,
exhibit
cell
properties
they
can
receive
transmit
signals
partly
via
release
inflammatory
effectors
in
pathological
conditions.
express
innate
receptors,
including
toll
like
receptors
(TLRs)
inflammasomes
first
sensors
exogenous
or
endogenous
dangers
initiators
responses
drive
neural
dysfunction
degeneration.
Accumulating
evidence
indicates
activation
TLRs
compromises
integrity,
promotes
aberrant
neuroimmune
interactions
modulates
both
systemic
neuroinflammation,
common
features
neurodegenerative
psychiatric
diseases
central
nervous
system
(CNS)
infections
injuries.
The
goal
present
review
is
provide
an
overview
pivotal
roles
played
discuss
molecular
cellular
mechanisms
contribute
disruption
neuroinflammation
especially
context
traumatic
ischemic
injuries
infections.
We
will
focus
on
most
recent
advances
literature
reports
field
highlight
knowledge
gaps.
future
research
directions
advance
our
understanding
contribution
potential
at
promising
therapeutic
targets
wide
variety
conditions
npj Vaccines,
Journal Year:
2021,
Volume and Issue:
6(1)
Published: Oct. 28, 2021
Abstract
Toll-like
receptors
(TLRs)
are
transmembrane
proteins
belonging
to
the
family
of
pattern-recognition
receptors.
They
function
as
sensors
invading
pathogens
through
recognition
pathogen-associated
molecular
patterns.
After
their
engagement
by
microbial
ligands,
TLRs
trigger
downstream
signaling
pathways
that
culminate
into
transcriptional
upregulation
genes
involved
in
immune
defense.
Here
we
provide
an
updated
overview
on
members
TLR
and
focus
role
antiviral
response.
Understanding
innate
sensing
viruses
triggered
these
would
useful
knowledge
prompt
development
vaccines
able
elicit
effective
long-lasting
responses.
We
describe
mechanisms
developed
viral
escape
from
surveillance
mediated
finally
discuss
how
TLR/virus
interplay
might
be
exploited
guide
design
innovative
vaccine
platforms.
Frontiers in Cell and Developmental Biology,
Journal Year:
2021,
Volume and Issue:
9
Published: Oct. 4, 2021
Toll-like
receptors
(TLRs)
are
the
pattern
recognition
receptors,
which
activated
by
foreign
and
host
molecules
in
order
to
initiate
immune
response.
They
play
a
crucial
role
regulation
of
innate
immunity,
several
studies
have
shown
their
importance
bacterial,
viral,
fungal
infections,
autoimmune
diseases,
cancers.
The
consensus
view
from
an
immunological
perspective
is
that
TLR
agonists
can
serve
either
as
possible
therapeutic
agent
or
vaccine
adjuvant
toward
cancers
infectious
diseases
inhibitors
may
be
promising
approach
treatment
some
cancers,
viral
infections.
These
notions
based
on
fact
stimulate
secretion
proinflammatory
cytokines
general,
development
responses.
Some
TLR-based
inhibitory
agents
efficacious
preclinical
models
now
entered
clinical
trials.
Therefore,
TLRs
seem
hold
potential
perfect
target
era
immunotherapies.
We
offer
therapeutics
sheds
light
usefulness
combination
therapies.
also
highlight
various
discovery
phase